ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment
The risk assessment model formulated in our research stands as a formidable instrument for forecasting BLCA prognosis, while also providing insights into the disease's progression mechanisms and guiding clinical decision-making strategies.
Authors
- Weiping Luo (ORCID: https://orcid.org/0000-0002-6041-4366)
- Zhenyu Hang
- You‐Yang Zhao (ORCID: https://orcid.org/0000-0002-0041-0339)
- Ke Jiang (ORCID: https://orcid.org/0000-0003-3808-111X)
- Li Wang (ORCID: https://orcid.org/0000-0001-7692-5067)
- Zihao Li (ORCID: https://orcid.org/0000-0002-0034-1783)
- Hongxiang Ma
- Chao Qin (ORCID: https://orcid.org/0000-0003-1915-4272)
- Xi Zhang (ORCID: https://orcid.org/0009-0000-2861-0626)
- Jun Fan (ORCID: https://orcid.org/0000-0002-5445-437X)
- Jun Nie
- Haojie Dai (ORCID: https://orcid.org/0009-0005-8399-8551)
- Xin Huang (ORCID: https://orcid.org/0000-0002-8505-8425)
- Ming Wu
Institutions
- Nanjing Medical University (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1186/s41065-025-00409-4
- Citations
- 11
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 22.07